SF-36 total score as a single measure of health-related quality of life: Scoping review

L Lins, FM Carvalho - SAGE open medicine, 2016 - journals.sagepub.com
According to the 36-Item Short Form Health Survey questionnaire developers, a global
measure of health-related quality of life such as the “SF-36 Total/Global/Overall Score” …

Gabapentin for chronic neuropathic pain in adults

PJ Wiffen, S Derry, RF Bell, ASC Rice… - Cochrane Database …, 2017 - cochranelibrary.com
Background Gabapentin is commonly used to treat neuropathic pain (pain due to nerve
damage). This review updates a review published in 2014, and previous reviews published …

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the …

S Tesfaye, G Sloan, J Petrie, D White, M Bradburn… - The Lancet, 2022 - thelancet.com
Background Diabetic peripheral neuropathic pain (DPNP) is common and often distressing.
Most guidelines recommend amitriptyline, duloxetine, pregabalin, or gabapentin as initial …

Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets

S Dewanjee, S Das, AK Das, N Bhattacharjee… - European journal of …, 2018 - Elsevier
Diabetic neuropathy is regarded as one of the most debilitating outcomes of diabetes
mellitus and may cause pain, decreased motility, and even amputation. Diabetic neuropathy …

A comprehensive algorithm for management of neuropathic pain

D Bates, BC Schultheis, MC Hanes, SM Jolly… - Pain …, 2019 - academic.oup.com
Background The objective of this review was to merge current treatment guidelines and best
practice recommendations for management of neuropathic pain into a comprehensive …

Neuropathic pain: mechanisms and their clinical implications

SP Cohen, J Mao - Bmj, 2014 - bmj.com
Neuropathic pain can develop after nerve injury, when deleterious changes occur in injured
neurons and along nociceptive and descending modulatory pathways in the central nervous …

A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on oral …

A Wolff, RK Joshi, J Ekström, D Aframian… - Drugs in R&d, 2017 - Springer
Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …

[HTML][HTML] Diabetic neuropathic pain: physiopathology and treatment

AK Schreiber, CFM Nones, RC Reis… - World journal of …, 2015 - ncbi.nlm.nih.gov
Diabetic neuropathy is a common complication of both type 1 and type 2 diabetes, which
affects over 90% of the diabetic patients. Although pain is one of the main symptoms of …

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

R Baron, A Binder, G Wasner - The Lancet Neurology, 2010 - thelancet.com
Neuropathic pain develops as a result of lesions or disease affecting the somatosensory
nervous system either in the periphery or centrally. Examples of neuropathic pain include …

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

N Attal, G Cruccu, R Baron, M Haanpää… - European journal of …, 2010 - Wiley Online Library
Background and objectives: This second European Federation of Neurological Societies
Task Force aimed at updating the existing evidence about the pharmacological treatment of …